ArticleAdvances in therapy2014

Cost-effectiveness of second-line chemotherapy/biologics among elderly metastatic colon cancer patients.

Zhiyuan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.